Supplemental material for The synthetic glycolipid-based TLR4 antagonist FP7 negatively regulates <i>in vitro</i> and <i>in vivo</i> haematopoietic and non-haematopoietic vascular TLR4 signalling

<p>Supplemental material for The synthetic glycolipid-based TLR4 antagonist FP7 negatively regulates <i>in vitro</i> and <i>in vivo</i> haematopoietic and non-haematopoietic vascular TLR4 signalling by Charys Palmer, Francesco Peri, Frank Neumann, Feroz Ahmad, David S. Leake and Grisha Pirianov in Innate Immunity</p>